Gregorj C, Petrucci MT, De Cave F, Scerpa MC, Vitale A, Ricciardi MR, Precupanu C, Cimino G, Mancini M, Vignetti M, Milella M, Andreeff M , Mandelli F, Foa R, Tafuri A
The downregulation of NEAT1 disrupts the transcriptional activation of NLRP3 by Kruppel-like factor 4 (KLF4), resulting in reduced expression of NLRP3
For more on managing early symptoms, read our blog on GLP-1 side effects: nausea, digestive changes, and when to call a clinician
Pen Dosage Chart Dosage & Protocols Variations Standard Research Protocol Dose: 0.1 0.2 mg (= 24 clicks) Duration: 8 12 weeks Frequency: Daily, before sleep Cycle Interval: 4 weeks off before repeating Goal / Description: Baseline GHRH stimulation studied for pulsatile GH release and IGF-1 modulation
Most patients see initial improvements within 3-4 weeks , with continued progress over months